ACCESSIBILITY

24/7

Headlines

16:48

Full list of Israeli startup M&As in 2024

16:46

Wiz acquires Dazz for $450 million to strengthen AI-driven cloud security

13:10

Walmart’s Director of Machine Learning on the future of the domain

12:37

IANUA Market launches Israel arm to connect investors to global network

Buzz

Most popular

Daily

Weekly

Cyera doubles valuation to $3B with $300M Series D, total funding hits $600M in seven months

Claroty veterans launch Twine with $12M in Seed funding from Dell and Wiz founders to deploy AI cyber workers

Salesforce seals $1.9 billion cash deal to acquire cloud backup company Own

Prompt Security raises $18 million Series A to protect enterprises from GenAI risks

Salesforce to slash jobs at Own after $1.9B acquisition finalized

More news

Women's Health

15 stories about Women's Health

OCON Therapeutics raises $10 million for innovative IUD and women’s health solutions

16.07.24|Ariela Karmel

The Israeli women’s health company has raised a total of $40 million to expand its health solutions including painless and effective IUDs and treatment for endometriosis and uterine fibroids

The Israeli startup developing the first new, non-hormonal contraceptive in 60 years

03.04.24|Ariela Karmel

Hervana Bio Founder and CEO Rachel Teitelbaum spoke to CTech about their innovative new non-hormonal contraceptive with no side effects and with added protection against STIs, and about why funding is needed to access the $25 billion contraceptive market

“FemTech is a national need in Japan”

27.03.24|Ariela Karmel

Co-Founder and CEO of Network in Motion, Ira Prigat, spoke to CTech about the potential for Israeli tech in the Japanese market, and how Israeli FemTech is perfectly suited to address Japan’s unique population crisis, which has led the government to designate raising the fertility rate and women’s health solutions as a national goal

The next FemTech frontier: personalized and innovative birth control

26.03.24|Ariela Karmel

Dr. Yael Maizels, formerly the Senior Scientist at the Institute for Personalized and Translational Medicine at Ariel University, has conducted a new study which shows that 76% of women suffer from non-lethal side effects from hormonal birth control. She spoke to CTech about the need for investment in personalized and innovative solutions for women

"If investors are disappointed with other sectors it’s a good time to explore FemTech"

05.10.23|Ariela Karmel

Lawyer and FemTech advocate Tal Tirosh sat down with CTech to discuss challenges and insights regarding expanding investment in the booming sector and presented her 5 strategies to increase investment in FemTech

“We're selling the normalization of menstruation and women’s bodies”

23.07.23|Ariela Karmel

Co-founder and CEO of Modibodi Israel Chen Tamir on how Modibodi is addressing economic discrimination, period poverty and social stigma surrounding menstruation

Shlomit Yehudai-Reshef, Inbal Zafir-Lavie, Valeria Miller, Shiri Blumenfeld-Kan, Zohar Shneider

Nevia Bio is using AI to early detect “silent killer” ovarian cancer

16.07.23|Ariela Karmel

Co-founder and CEO Dr. Inbal Zafir-Lavie spoke to CTech about Nevia Bio’s mission to democratize preventative medicine and make ovarian cancer screenings accessible to all

NOGAFem: Bringing gendered medicine to the forefront

12.07.23|Ariela Karmel

Co-founders of NOGAFem, Dr. Michal Sela and Dr. Ronell Klingman, spoke to CTech about their efforts to bring a gendered lens to healthcare and innovation

OCON Therapeutics improves women's quality of life with innovative IUD design and targeted health solutions

02.07.23|Ariela Karmel

CEO Keren Leshem spoke to CTech about how OCON is pioneering painless and effective IUDs for women and addressing prevalent women's health issues like endometriosis and uterine fibroids

FEMSelect transforms women's quality of life with innovative pelvic floor solutions

28.06.23|Ariela Karmel

CEO of FEMSelect, Debbie Garner, spoke to CTech about FEMSelect’s mission to enhance women's quality of life through their solution for pelvic organ prolapse

"51% is not a niche": Startup studio impact.51 on mission to revolutionize FemTech

20.06.23|Ariela Karmel

Co-founders of impact.51, Michal Shalem and Michal Lebenthal Andreson, spoke to CTech about establishing the first studio in the world focused exclusively on women’s health solutions

Cannabis Lab Set Up in Hebrew University With $2.3 Million Investment

15.10.18|Amitay Gazit

The investment was made by Asana Bio Group, an Israeli company specializing in cannabinoid-based treatments in the women's health field

At Swiss Pharma Company, Women’s Health Gets Personal

23.05.18|Lilach Baumer

Ferring Pharmaceuticals recently launched a personalized fertility treatment that supports its hormone therapy with a dosage calculation app

Teva Sells Remaining Women's Health Assets

18.09.17|Lilach Baumer

After selling its Paragard business for $1.1 billion last week, Teva's remaining Women's Health business will be split between CVC Capital Partners and Foundation Consumer Healthcare in a $1.38 billion cash deal

Teva Negotiating Sale of Remaining Women's Health Assets, Report Says

14.09.17|Lilach Baumer

CVC Capital Partners is nearing a $800 million deal for Teva's remaining Women's Health business, Bloomberg reported Thursday